Through NGS, we identified a novel BCR-ABL1 fusion gene with breakpoints in the BCR intron 14 and the ABL1 intron 2, respectively, in a rare case of CML. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.